Improved Skin Permeation of Methotrexate Via Nanosized Ultradeformable Liposomes

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2016 Aug 20

PMID 27540293

Citations 51

Authors

Alam Zeb

Omer Salman Qureshi

Hyung-Seo Kim

Ji-Hye Cha

Hoo-Seong Kim

Jin-Ki Kim

Affiliations

Soon will be listed here.

Abstract

The aim of this study is to investigate methotrexate-entrapped ultradeformable liposomes (MTX-UDLs) for potential transdermal application. MTX-UDLs were prepared by extrusion method with phosphatidylcholine as a bilayer matrix and sodium cholate or Tween 80 as an edge activator. The physicochemical properties of MTX-UDLs were determined in terms of particle size, polydispersity index, zeta potential, and entrapment efficiency. The deformability of MTX-UDLs was compared with that of methotrexate-entrapped conventional liposomes (MTX-CLs) using a steel pressure filter device. The skin permeation of MTX-UDLs was investigated using Franz diffusion cell, and the skin penetration depth of rhodamine 6G-entrapped UDLs was determined by confocal laser scanning microscopy. MTX-UDLs showed a narrow size distribution, with the particle size of ~100 nm. The deformability of MTX-UDLs was two to five times greater than that of MTX-CLs. The skin permeation of MTX-UDLs was significantly improved compared with MTX-CLs and free MTX solution. The optimized UDLs (phosphatidylcholine: Tween 80 =7:3, w/w) showed a higher fluorescence intensity than conventional liposomes at every increment of skin depth. Thus, the optimized UDLs could be promising nanocarriers for systemic delivery of MTX across skin.

Citing Articles

Targeted nanoliposomes for precision rheumatoid arthritis therapy: a review on mechanisms and potential.

Girase R, Gujarathi N, Sukhia A, Kota S, Patil T, Aher A Drug Deliv. 2025; 32(1):2459772.

PMID: 39891600 PMC: 11789225. DOI: 10.1080/10717544.2025.2459772.

Mechanistic insights of desmopressin loaded elastic liposomes for transdermal delivery: HSPiP predictive parameters and instrumental based evidences.

Hussain A, Altamimi M, Alshammari M Int J Pharm X. 2024; 8:100304.

PMID: 39640078 PMC: 11617381. DOI: 10.1016/j.ijpx.2024.100304.

Plant-Based Nanovesicular Gel Formulations Applied to Skin for Ameliorating the Anti-Inflammatory Efficiency.

Atia H, Shahien M, Ibrahim S, Haridy Ahmed E, Elariny H, Abdallah M Gels. 2024; 10(8).

PMID: 39195054 PMC: 11353947. DOI: 10.3390/gels10080525.

Berberine HCl and diacerein loaded dual delivery transferosomes: Formulation and optimization using Box-Behnken design.

Singh S, Awasthi R ADMET DMPK. 2024; 12(3):553-580.

PMID: 39091899 PMC: 11289510. DOI: 10.5599/admet.2268.

Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis.

Mohammad S, Aldosari B, Mehanni M, El-Gendy A, Hozayen W, Afzal O Int J Pharm X. 2024; 7:100247.

PMID: 38706465 PMC: 11066576. DOI: 10.1016/j.ijpx.2024.100247.

References

Li G, Fan Y, Fan C, Li X, Wang X, Li M . Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm. 2012; 82(1):49-57. DOI: 10.1016/j.ejpb.2012.05.011. View

Singka G, Samah N, Zulfakar M, Yurdasiper A, Heard C . Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. Eur J Pharm Biopharm. 2010; 76(2):275-81. DOI: 10.1016/j.ejpb.2010.06.014. View

Dubey V, Mishra D, Asthana A, Jain N . Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 2006; 27(18):3491-6. DOI: 10.1016/j.biomaterials.2006.01.060. View

Cevc G, Schatzlein A, Richardsen H . Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 2002; 1564(1):21-30. DOI: 10.1016/s0005-2736(02)00401-7. View

Pinto M, Moura C, Nunes C, Segundo M, Costa Lima S, Reis S . A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm. 2014; 477(1-2):519-26. DOI: 10.1016/j.ijpharm.2014.10.067. View

Lv Q, Yu A, Xi Y, Li H, Song Z, Cui J . Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 2009; 372(1-2):191-8. DOI: 10.1016/j.ijpharm.2009.01.014. View

Yang F, Kamiya N, Goto M . Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier. Eur J Pharm Biopharm. 2012; 82(1):158-63. DOI: 10.1016/j.ejpb.2012.05.016. View

Yang T, Cui F, Choi M, Cho J, Chung S, Shim C . Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int J Pharm. 2007; 338(1-2):317-26. DOI: 10.1016/j.ijpharm.2007.02.011. View

Cevc G, Gebauer D, Stieber J, Schatzlein A, Blume G . Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta. 1998; 1368(2):201-15. DOI: 10.1016/s0005-2736(97)00177-6. View

10.

Chen A, Chen L, Wang S, Wang Y, Zha J . Study of magnetic silk fibroin nanoparticles for massage-like transdermal drug delivery. Int J Nanomedicine. 2015; 10:4639-51. PMC: 4516257. DOI: 10.2147/IJN.S85999. View

11.

Stagni G, Shukla C . Pharmacokinetics of methotrexate in rabbit skin and plasma after iv-bolus and iontophoretic administrations. J Control Release. 2003; 93(3):283-92. DOI: 10.1016/j.jconrel.2003.08.011. View

12.

Jain S, Jain P, Umamaheshwari R, Jain N . Transfersomes--a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003; 29(9):1013-26. DOI: 10.1081/ddc-120025458. View

13.

Dubey V, Mishra D, Jain N . Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm. 2007; 67(2):398-405. DOI: 10.1016/j.ejpb.2007.03.007. View

14.

Cevc G, Blume G . Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992; 1104(1):226-32. DOI: 10.1016/0005-2736(92)90154-e. View

15.

Ruozi B, Belletti D, Tombesi A, Tosi G, Bondioli L, Forni F . AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study. Int J Nanomedicine. 2011; 6:557-63. PMC: 3065801. DOI: 10.2147/IJN.S14615. View

16.

Elsayed M, Abdallah O, Naggar V, Khalafallah N . Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen. Pharmazie. 2007; 62(2):133-7. View

17.

Lee E, Kim A, Oh Y, Kim C . Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials. 2004; 26(2):205-10. DOI: 10.1016/j.biomaterials.2004.02.020. View

18.

Barry B . Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 2001; 14(2):101-14. DOI: 10.1016/s0928-0987(01)00167-1. View

19.

El Zaafarany G, Awad G, Holayel S, Mortada N . Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010; 397(1-2):164-72. DOI: 10.1016/j.ijpharm.2010.06.034. View

20.

Kang M, Eum J, Jeong M, Choi S, Park S, Cho H . Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biol Pharm Bull. 2010; 33(1):100-6. DOI: 10.1248/bpb.33.100. View